{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:59:57Z","timestamp":1778914797140,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroblastoma (NB) tumor rupture is a rare oncology emergency with a poor prognosis. We aimed to evaluate patient clinical characteristics and risk factors for ruptured NB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study of 47 patients with confirmed NB rupture between January 2009 and January 2019 at Beijing Children\u2019s Hospital was conducted. To identify tumor rupture risk factors in high-risk NB patients, we included 93 consecutive non-ruptured high-risk NB patients from January 2017 to January 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age at presentation was 29\u2009months (adrenal and retroperitoneum origin) for 47 ruptured NB patients. Spontaneous tumor rupture occurred in 22 cases; 18 cases occurred during or after the first chemotherapy cycle, and 7 occurred after core needle biopsy. Five patients died of tumor rupture, and 17 patients\u2019 parents refused further antitumor therapy. Among the 25 remaining patients, 6 survived without disease, 5 received ongoing treatment and achieved stable disease, and 14 died. According to multivariate logistic regression analysis, a maximum primary tumor diameter\u2009&gt;\u200913.20\u2009cm and\n                      <jats:italic>MYCN<\/jats:italic>\n                      gene amplification were independent risk factors for tumor rupture within high-risk NB.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Tumor rupture is an uncommon, life-threatening event for NB patients; these patients are most likely to have poor outcomes due to tumor recurrence or rapid progression. Several treatment modalities, including symptomatic support therapy and chemotherapy, are important for saving lives and for developing NB risk-based treatment in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-06720-9","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T09:04:09Z","timestamp":1584954249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical characteristics and risk factors of 47 cases with ruptured neuroblastoma in children"],"prefix":"10.1186","volume":"20","author":[{"given":"Hong","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"6720_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/MPH.0b013e3182678e1e","volume":"34","author":"S Honda","year":"2012","unstructured":"Honda S, Miyagi H, Minato M, et al. Hemorrhagic shock due to spontaneous rupture of adrenal neuroblastoma in an infant: a rare case and review of the literature. J Pediatr Hematol Oncol. 2012;34:635\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"6720_CR2","first-page":"359","volume":"13","author":"M Mascarin","year":"1991","unstructured":"Mascarin M, De Bernardi B, Brisigotti M, et al. Neuroblastoma. Tumor rupture as an unfavorable prognostic factor. Pediatr Med Chir. 1991;13:359\u201363.","journal-title":"Pediatr Med Chir"},{"key":"6720_CR3","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","volume":"11","author":"GM Brodeur","year":"1993","unstructured":"Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466\u201377.","journal-title":"J Clin Oncol"},{"key":"6720_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","volume":"27","author":"T Monclair","year":"2009","unstructured":"Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27:298\u2013303.","journal-title":"J Clin Oncol"},{"key":"6720_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2009","unstructured":"Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009;27:289\u201397.","journal-title":"J Clin Oncol"},{"key":"6720_CR6","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/cncr.11773","volume":"98","author":"M Peuchmaur","year":"2003","unstructured":"Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the international neuroblastoma pathology classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer. 2003;98:2274\u201381.","journal-title":"Cancer."},{"key":"6720_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12935-018-0521-3","volume":"18","author":"C Duan","year":"2018","unstructured":"Duan C, Wang H, Chen Y, et al. Whole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy. Cancer Cell Int. 2018;18:21.","journal-title":"Cancer Cell Int"},{"key":"6720_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1200\/JCO.2012.45.9339","volume":"31","author":"T Simon","year":"2013","unstructured":"Simon T, Haberle B, Hero B, et al. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol. 2013;31:752\u20138.","journal-title":"J Clin Oncol"},{"key":"6720_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0022-3468(78)80208-5","volume":"13","author":"TV Murthy","year":"1978","unstructured":"Murthy TV, Irving IM, Lister J. Massive adrenal hemorrhage in neonatal neuroblastoma. J Pediatr Surg. 1978;13:31\u20134.","journal-title":"J Pediatr Surg"},{"key":"6720_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s002470050769","volume":"30","author":"D Vora","year":"2000","unstructured":"Vora D, Slovis TL, Boal DK. Hemoperitoneum and disseminated intravascular coagulation in two neonates with congenital bilateral neuroblastoma. Pediatr Radiol. 2000;30:394\u20137.","journal-title":"Pediatr Radiol"},{"key":"6720_CR11","first-page":"370","volume":"136","author":"CE Brock","year":"1982","unstructured":"Brock CE, Ricketts RR. Hemoperitoneum from spontaneous rupture of neonatal neuroblastoma. Am J Dis Child. 1982;136:370\u20131.","journal-title":"Am J Dis Child"},{"key":"6720_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/s-2006-924605","volume":"16","author":"C Normand","year":"2006","unstructured":"Normand C, Leblond P, Mazingue F, et al. A case of adrenal haemorrhage after minor trauma in a young child: think of neuroblastoma. Eur J Pediatr Surg. 2006;16:365\u20138.","journal-title":"Eur J Pediatr Surg"},{"key":"6720_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/archsurg.136.6.682","volume":"136","author":"LX Zhu","year":"2001","unstructured":"Zhu LX, Geng XP, Fan ST. Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg. 2001;136:682\u20137.","journal-title":"Arch Surg"},{"key":"6720_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1447-0756.2011.01748.x","volume":"38","author":"M Shiota","year":"2012","unstructured":"Shiota M, Kotani Y, Umemoto M, et al. Study of the correlation between tumor size and cyst rupture in laparotomy and laparoscopy for benign ovarian tumor: is 10 cm the limit for laparoscopy? J Obstet Gynaecol Res. 2012;38:531\u20134.","journal-title":"J Obstet Gynaecol Res"},{"key":"6720_CR15","first-page":"4596","volume":"60","author":"S Breit","year":"2000","unstructured":"Breit S, Ashman K, Wilting J, et al. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin a. Cancer Res. 2000;60:4596\u2013601.","journal-title":"Cancer Res"},{"key":"6720_CR16","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1038\/onc.2008.15","volume":"27","author":"J Kang","year":"2008","unstructured":"Kang J, Rychahou PG, Ishola TA, et al. N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma. Oncogene. 2008;27:3999\u20134007.","journal-title":"Oncogene."},{"key":"6720_CR17","first-page":"531","volume":"43","author":"P Takvorian","year":"1988","unstructured":"Takvorian P, Floret D, Valette PJ, et al. Hepatic rupture after puncture biopsy: value of embolization. Apropos of a case with hepatoblastoma. Pediatrie. 1988;43:531\u20133.","journal-title":"Pediatrie."},{"key":"6720_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejrad.2014.11.038","volume":"84","author":"A Hiraoka","year":"2015","unstructured":"Hiraoka A, Kawamura T, Aibiki T, et al. Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy. Eur J Radiol. 2015;84:366\u201371.","journal-title":"Eur J Radiol"},{"key":"6720_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.amjsurg.2007.10.016","volume":"197","author":"N Battula","year":"2009","unstructured":"Battula N, Madanur M, Priest O, et al. Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg. 2009;197:164\u20137.","journal-title":"Am J Surg"},{"key":"6720_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1258\/ar.2010.100369","volume":"52","author":"BS Shin","year":"2011","unstructured":"Shin BS, Park MH, Jeon GS. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization. Acta Radiol. 2011;52:331\u20135.","journal-title":"Acta Radiol"},{"key":"6720_CR21","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1200\/JCO.2010.34.3392","volume":"29","author":"WB London","year":"2011","unstructured":"London WB, Castel V, Monclair T, et al. Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2011;29:3286\u201392.","journal-title":"J Clin Oncol"},{"key":"6720_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1200\/JCO.2016.67.2642","volume":"35","author":"D von Allmen","year":"2017","unstructured":"von Allmen D, Davidoff AM, London WB, et al. Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol. 2017;35:208\u201316.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06720-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-06720-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06720-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T20:10:19Z","timestamp":1616443819000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-06720-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6720"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06720-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.16715\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16715\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16715\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16715\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"16 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations, and the study was approved by the Medical Ethics Committee of Beijing Children\u2019s Hospital (2017-k-89). A waiver of consent was awarded to conduct analyses in this study due to the retrospective nature of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"243"}}